-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Protagenic Therapeutics, Inc.\new quarterly/annual Earnings Per Share, Basic history and growth rate from 2014 to 2023.
- Protagenic Therapeutics, Inc.\new Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.14 USD/shares, a 56.3% increase year-over-year.
- Protagenic Therapeutics, Inc.\new Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.27 USD/shares, a 39.6% decline year-over-year.
- Protagenic Therapeutics, Inc.\new annual Earnings Per Share, Basic for 2023 was -1.15 USD/shares, a 40.2% decline from 2022.
- Protagenic Therapeutics, Inc.\new annual Earnings Per Share, Basic for 2022 was -0.82 USD/shares, a 33.9% increase from 2021.
- Protagenic Therapeutics, Inc.\new annual Earnings Per Share, Basic for 2021 was -1.24 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)